All published articles of this journal are available on ScienceDirect.

RESEARCH ARTICLE

LETTER TO THE EDITOR Screening for Fingolimod Associated Macular Oedema: Experience Versus Guidelines

The Open Ophthalmology Journal 3 Oct 2014 RESEARCH ARTICLE DOI: 10.2174/1874364101408010073

Abstract

We report adherence to United Kingdom national guidelines on surveillance for Fingolimod associated macular oedema (FAME) and the impact on clinical services at our unit. We conducted a 9-month study, measuring referral interval, visual function and performing OCT scans for all patients referred for FAME surveillance. 38 patients in total were seen, representing 9% of all new ophthalmic referrals during the study period. 26% were seen between 2 and 4 months after starting Fingolimod treatment, 74% between 3 and 4 months after starting Fingolimod treatment. The impact on clinical services is discussed.

Keywords: Fingolimod, guidelines, macular oedema, screening.
Fulltext HTML PDF
1800
1801
1802
1803
1804